• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABL1是一种预后标志物,与肝细胞癌中的免疫浸润相关。

ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma.

作者信息

Liu Rongqiang, Kong Weihao, Jiang ZeKun, Zheng Shiyang, Yuan Xiaofeng, Ye Linsen

机构信息

Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510220, Guangdong, China.

出版信息

J Oncol. 2021 Aug 26;2021:1379706. doi: 10.1155/2021/1379706. eCollection 2021.

DOI:10.1155/2021/1379706
PMID:34484330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8413061/
Abstract

BACKGROUND

The role of ABL1 in hepatocellular carcinoma (HCC) is still unclear. Therefore, this study aims to explore the potential role of ABL1 in the progression of HCC using bioinformatics methods.

METHODS

We analyzed the expression, prognostic potential, and immune cell effect of ABL1 in HCC by using a variety of datasets.

RESULTS

ABL1 is highly expressed in HCC and associated with unfavorable overall survival (OS) and disease-free survival (DFS). Functional network analysis revealed that ABL1 plays an important role in mitochondrial activity, ATP metabolism, protein translation and metabolism, various neurological diseases, nonalcoholic fatty liver disease, and notch signaling pathway. In addition, we found that ABL1 expression was closely correlated with B cells, CD8 + T cells, CD4 + T cells, macrophages, neutrophils, and dendritic cells. Furthermore, ABL1 expression was positively associated with the expression levels of immune checkpoint genes, such as PD-1L, TIM3, TIGIT, and CTLA4.

CONCLUSION

ABL1 is associated with immune infiltration and prognosis of HCC.

摘要

背景

ABL1在肝细胞癌(HCC)中的作用仍不明确。因此,本研究旨在运用生物信息学方法探索ABL1在HCC进展中的潜在作用。

方法

我们通过使用多种数据集分析了ABL1在HCC中的表达、预后潜力和免疫细胞效应。

结果

ABL1在HCC中高表达,且与不良的总生存期(OS)和无病生存期(DFS)相关。功能网络分析显示,ABL1在线粒体活性、ATP代谢、蛋白质翻译与代谢、各种神经疾病、非酒精性脂肪性肝病以及Notch信号通路中发挥重要作用。此外,我们发现ABL1表达与B细胞、CD8 + T细胞、CD4 + T细胞、巨噬细胞、中性粒细胞和树突状细胞密切相关。此外,ABL1表达与免疫检查点基因如PD-1L、TIM3、TIGIT和CTLA4的表达水平呈正相关。

结论

ABL1与HCC的免疫浸润和预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/d2a125363e2f/JO2021-1379706.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/32a26f26af9d/JO2021-1379706.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/d006b1960723/JO2021-1379706.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/39c1265c4d6e/JO2021-1379706.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/b0bb7ed0e057/JO2021-1379706.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/9739f0657603/JO2021-1379706.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/fa2b790c40af/JO2021-1379706.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/d2a125363e2f/JO2021-1379706.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/32a26f26af9d/JO2021-1379706.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/d006b1960723/JO2021-1379706.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/39c1265c4d6e/JO2021-1379706.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/b0bb7ed0e057/JO2021-1379706.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/9739f0657603/JO2021-1379706.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/fa2b790c40af/JO2021-1379706.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4eb0/8413061/d2a125363e2f/JO2021-1379706.007.jpg

相似文献

1
ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma.ABL1是一种预后标志物,与肝细胞癌中的免疫浸润相关。
J Oncol. 2021 Aug 26;2021:1379706. doi: 10.1155/2021/1379706. eCollection 2021.
2
CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.CPNE1是一种潜在的预后生物标志物,与免疫浸润相关,并促进肝细胞癌的进展。
Cancer Cell Int. 2022 Feb 9;22(1):67. doi: 10.1186/s12935-022-02485-2.
3
NTF3 Correlates With Prognosis and Immune Infiltration in Hepatocellular Carcinoma.NTF3与肝细胞癌的预后和免疫浸润相关。
Front Med (Lausanne). 2021 Dec 6;8:795849. doi: 10.3389/fmed.2021.795849. eCollection 2021.
4
Integrated Analysis of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma.肝细胞癌中肿瘤突变负荷与免疫浸润的综合分析
Diagnostics (Basel). 2022 Aug 8;12(8):1918. doi: 10.3390/diagnostics12081918.
5
AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.AUNIP表达与免疫浸润相关,是肝细胞癌和肺腺癌的候选诊断及预后生物标志物。
Front Oncol. 2020 Dec 9;10:590006. doi: 10.3389/fonc.2020.590006. eCollection 2020.
6
LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.LMNB2 是肝细胞癌的预后生物标志物,并与免疫浸润相关。
IUBMB Life. 2020 Dec;72(12):2672-2685. doi: 10.1002/iub.2408. Epub 2020 Nov 19.
7
DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.DCK是一种很有前景的预后生物标志物,与肝细胞癌中的免疫浸润相关。
World J Surg Oncol. 2020 Jul 20;18(1):176. doi: 10.1186/s12957-020-01953-1.
8
Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.羟甾体 17-β 脱氢酶 6 是肝癌的预后生物标志物,并与免疫浸润相关。
Dig Dis Sci. 2022 Jan;67(1):146-158. doi: 10.1007/s10620-021-06832-7. Epub 2021 Jan 26.
9
Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.SIRT7 缺失通过 MEF2D 调控程序性细胞死亡配体 1 增加肝癌细胞中检查点抑制剂的疗效。
Gastroenterology. 2020 Feb;158(3):664-678.e24. doi: 10.1053/j.gastro.2019.10.025. Epub 2019 Oct 31.
10
Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network.基于竞争性内源性RNA网络的肝细胞癌预后生物标志物鉴定及其与免疫浸润的相关性
Front Genet. 2021 May 20;12:591623. doi: 10.3389/fgene.2021.591623. eCollection 2021.

引用本文的文献

1
Overexpression of miR-532-5p restrains oxidative stress response of chondrocytes in nontraumatic osteonecrosis of the femoral head by inhibiting ABL1.miR-532-5p的过表达通过抑制ABL1抑制股骨头非创伤性骨坏死中软骨细胞的氧化应激反应。
Open Med (Wars). 2024 Mar 30;19(1):20240943. doi: 10.1515/med-2024-0943. eCollection 2024.
2
Genome-wide association study reveals the genetic determinism of serum biochemical indicators in ducks.全基因组关联研究揭示了鸭血清生化指标的遗传决定因素。
BMC Genomics. 2022 Dec 27;23(1):856. doi: 10.1186/s12864-022-09080-9.

本文引用的文献

1
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy.肝细胞癌发病机制、预后及治疗中的肿瘤相关中性粒细胞
Cancers (Basel). 2021 Jun 10;13(12):2899. doi: 10.3390/cancers13122899.
2
ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancers.ABL1 依赖性 OTULIN 磷酸化促进遗传毒性 Wnt/β-catenin 激活,从而增强乳腺癌的耐药性。
Nat Commun. 2020 Aug 7;11(1):3965. doi: 10.1038/s41467-020-17770-9.
3
ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
ABL1在肝细胞癌中过表达,调控NOTCH1的表达并促进小鼠肝脏肿瘤的发展。
Gastroenterology. 2020 Jul;159(1):289-305.e16. doi: 10.1053/j.gastro.2020.03.013. Epub 2020 Jun 24.
4
CD8+CXCR5+T cells infiltrating hepatocellular carcinomas are activated and predictive of a better prognosis.浸润肝细胞癌的CD8+CXCR5+T细胞被激活,且预示着更好的预后。
Aging (Albany NY). 2019 Oct 30;11(20):8879-8891. doi: 10.18632/aging.102308.
5
Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications.肝细胞癌微环境的免疫景观:对预后和治疗应用的影响。
Liver Int. 2019 Sep;39(9):1608-1621. doi: 10.1111/liv.14192. Epub 2019 Jul 28.
6
Accumulation of Tumor-Infiltrating CD49a NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma.肿瘤浸润性 CD49a NK 细胞的积累与人类肝细胞癌的不良预后相关。
Cancer Immunol Res. 2019 Sep;7(9):1535-1546. doi: 10.1158/2326-6066.CIR-18-0757. Epub 2019 Jul 16.
7
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection.肿瘤内浆细胞样树突状细胞是影响根治性切除术后肝细胞癌预后的不良因素。
Cancer Immunol Immunother. 2019 Aug;68(8):1223-1233. doi: 10.1007/s00262-019-02355-3. Epub 2019 Jun 14.
8
Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.RIG-I 缺陷型干性高的人肝癌细胞中激活的 TGF-β/Akt/Smad2 信号诱导免疫耐受树突状细胞。
BMC Cancer. 2019 May 14;19(1):439. doi: 10.1186/s12885-019-5670-9.
9
TISIDB: an integrated repository portal for tumor-immune system interactions.TISIDB:一个用于肿瘤-免疫系统相互作用的综合知识库门户。
Bioinformatics. 2019 Oct 15;35(20):4200-4202. doi: 10.1093/bioinformatics/btz210.
10
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.骨桥蛋白诱导集落刺激因子 1 信号破坏肿瘤相关巨噬细胞的迁移,使肝细胞癌对抗 PD-L1 阻断敏感。
Gut. 2019 Sep;68(9):1653-1666. doi: 10.1136/gutjnl-2019-318419. Epub 2019 Mar 22.